Fuji Pharma Co., Ltd.
Address
(ZIP code:939-3515） 1515 Mizuhashitsujigado, Toyama City, Toyama, Japan
Tel:+81-76-479-9000
Contract Manufacturing Promoting Section, Supply Chain Management Department
Hiroki MATSUKURA (Mr.)
Fuji Pharma Toyama Plant plans to install and start up the brand-new multiple-type syringes manufacutering line available for high potent products in 2023, and we are going to begin our new CMO business with this manufacturing line in 2024. This installation will contribute to the quality and flexibility of our CMO business.
The production of products for women's helth is the speciality of Fuji Pharma for almost a half of the century. Especially for our speciality, we have the long experience of the production of various hormone products with the quality containment technology. This experience is embodied not only in Fuji Pharma's own products but our CMO products as well.
High potent freeze-dried vial products and bio-similar products are also manufactured in our plants, and they are part of our core products.
Your request is our pleasure. Please don't hesitate to contact us. Your contact is always welcome!
| Production category | Large classification | Middle classification | Form of drug | Sub classification | Feature of the form | Capacity of commission (per year) | Contractable process | Main production machine | Production techniques | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Commissioned development | Investigational drug manufacturing | Commercial production | Packaging | |||||||||
| GMP manufacturing | Pharmaceutical formulation | Small molecule drugs（without highly potent drugs） | Preparations for Injection | Vials Prefilled syringes | ・Glass vial (2, 5, 10mL, high potent product available) ・Glass syringe（1, 2mL） ・Multiple type syringe（Y2024～, Nest-tub style, 1, 2, 5mL, and 10mL in future, high potent products available） | Negotiable | ● | ・Isolators for injectable products and freeze-dried products ・Containment equipment for high potent products (ventilation etc.) ・The plan to install the multiple type syringes manufacutering line available for high potent products in October 2023 | ・Quality containment technology ・Single use system for prepration available | |||
| Small molecule drugs（highly potent drugs） | ● | |||||||||||
| Nucleic acid medicine | ● | |||||||||||
| Peptide | ● | |||||||||||
| Antibodies/recombinant proteins | ● | |||||||||||
| Other polymers | ● | |||||||||||
